New podcast – More on vaccine equity and S/F vaccines in the Americas

In focus / 27 May 2021

Photo: iStock

Our latest podcast episode features the audio version of our article on vaccine equity in the Americas, followed by an interview with the author, Danini Marin.


Be sure to listen in to the new Drug Safety Matters podcast episode for the audio version of our recent article, "Substandard and falsified COVID-19 vaccines in the Americas: Can vaccine equity help?"

After the long read, the author of the article, Danini Marin, joins host Federica Santoro to dig deeper into the state of the COVAX programme in the region, how organised crime is taking advantage of the pandemic, and why substandard and falsified vaccines pose such a serious risk to public vaccination programmes.

Danini Marin
"Substandard and falsified vaccines will most likely negatively impact people’s trust in vaccines."

Subscribe by visiting the Drug Safety Matters website or listen in right here:

This episode is part of the Uppsala Reports Long Reads series – the most topical stories from UMC’s pharmacovigilance magazine, brought to you in audio format. Find the original article here.

After the read, we talk to Danini about the COVAX programme, organised crime, and trust in vaccinations.

You may also like


Pharmacovigilance in older adults – New podcast episode

Compared to the general population, older adults are more at risk of experiencing adverse drug reactions. Why is this the case, and what does this mean for pharmacovigilance?

In focus / 29 October 2024

Guarding nature: The role of ecopharmacovigilance in preventing pharmaceutical pollution

EcoPV aims to monitor and manage the environmental impact of pharmaceuticals. How may we best support this effort?

In focus / 01 September 2024

Ecopharmacovigilance: Ensuring environmental safety from pharmaceuticals

Pharmacovigilance monitors the safety of the medicines we use, but what about those that get into our environment?

In focus / 15 October 2024